During the past decade, Blue Sky Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Blue Sky Neurology" are "Glioblastoma" (1 trials), "Partial Epilepsy" (1 trials) and "Small Fiber Neuropathy" (1 trials). Many other conditions were trialed in "Blue Sky Neurology" in a lesser frequency.

Most popular intervention types in "Blue Sky Neurology" are "Drug" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Enzastaurin Hydrochloride" (1 trials), "Radiotherapy" (1 trials), "Temozolomide" (1 trials) and "VX-150" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blue Sky Neurology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Blue Sky Neurology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Blue Sky Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blue Sky Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".